https://www.selleckchem.com/products/myci361.html
738, P 0.001) and CD4+ T lymphocyte percentage (r = 0.616, P 0.001). The best cut-off value to predict a poor clinical outcome was 40 cells/μL during baseline CSF WCC. The predictive model incorporating longitudinal data of CSF WCC had better sensitivity, specificity, and accuracy than a model incorporating only baseline CSF WCC data. Our results indicated that baseline CSF WCC and changes in CSF WCC over time could be used to assess the prognosis of CM patients. Our results indicated that baseline CSF WCC and changes in CSF W